Rathbones Group’s Dianthus Therapeutics DNTH Stock Holding History

Rathbones Group’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-625	Closed	-$7.58K	–	635
2023 Q2	$7.58K	Hold	625	–	–	﹤0.01%	409
2023 Q1	$7.95K	Hold	625	–	–	﹤0.01%	412
2022 Q4	$3.95K	Hold	625	–	–	﹤0.01%	422
2022 Q3	$14K	Hold	625	–	–	﹤0.01%	414
2022 Q2	$12K	Buy	+625	New	+$15.4K	﹤0.01%	427

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return